SCHEMBL27484183

SCHEMBL27484183

NCc1cccc(NC(=O)c2ccccc2N)c1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FADS1 O60427 4/20 0.60
PTGS1 P23219 2/20 0.60
AURKB Q96GD4 1/20 0.60
P2RX1 P51575 1/20 0.52
ALDH1A1 P00352 2/20 0.50
PLG P00747 2/20 0.50
KLK1 P06870 2/20 0.50
KLK6 Q92876 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CFD P00746 1/20 0.50
KLKB1 P03952 1/20 0.49
TERT O14746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27483855 0.86 KLKB1 (0.64) FADS1PTGS1P2RX1PLGKLK1
SCHEMBL17744881 0.86 FADS1 (0.72) FADS1PTGS1P2RX1ALDH1A1KDM4E
SCHEMBL17538569 0.85 ALDH1A1 (0.63) AURKBALDH1A1PLGKLK1KLK6
SCHEMBL14018734 0.85 FADS1 (0.60) FADS1PTGS1P2RX1ALDH1A1KDM4E
SCHEMBL12264961 0.85 FADS1 (0.60) FADS1PTGS1AURKBP2RX1ALDH1A1
SCHEMBL23367948 0.84 SMN1; SMN2 (0.68) AURKBALDH1A1HPGDSMN1; SMN2
SCHEMBL27952999 0.84 AURKB (0.56) AURKBALDH1A1PLGKLK1KLK6
SCHEMBL20839480 0.83 ITGB3 (0.60) FADS1PTGS1P2RX1ALDH1A1
SCHEMBL27795055 0.83 PLG (0.60) AURKBPLGKLK1KLK6
SCHEMBL9810110 0.81 ALDH1A1 (0.72) FADS1PTGS1P2RX1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 CN disclosed